Focusing on biological extraction and purification, we specialise in cell culture growth and diagnostic applications. Our company has established a dependable supply chain of premium raw materials sourced from various New Zealand abattoirs.

We will manufacture:

·      Blood serum fractions

·      Serum formulations for enhanced cell growth

·      Targeted protein and peptide isolation for supply to the pharmaceutical arena

·      Supply of raw and intermediate ingredients, through to finished biologicals

Location

Based in Manawatu, New Zealand, we are utilising New Zealand’s superior animal disease status and government audited product traceability for worldwide supply of animal byproducts.

Key Personnel

Paul Lewis brings with him over 30 years of experience in biological extraction, quality and facility management. He’s successfully completed five facility builds with one site registered with full GMP license for manufacture of an API for a human injectable. His experience from R&D through to new product launch is a welcomed asset to the company.

Brand new facility currently under construction, opening Q2 in 2025.